World Biosimilar Sector Developments Traced by FirstWord in New Report ... DigitalJournal.com The leading amid the biosimilar and NCB development league is Rituximab (Rituxan/MabThera; Roche), possessing more than 30 individual programmes worldwide. The prospect of the world biosimilars market has been in development for a long period of ... |
